Catalyst Wire Dossier Catalyst Wire Dossier

Rucaparib (Rubraca)

Rucaparib · Clovis Oncology
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rucaparib (Rubraca), covering 2025-05-30 to 2025-05-30. Get the full timeline:

Most recent: Clinical Trial Update: The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib) [Phase 2]

See pricing